Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
Vita Coco
COCO
$3.73B
| $2.87M | ﹤0.01% |
67,640
-11,545
| -15% | -$428K |
|
2577
Fastly Inc
FSLY
$3.61B
| $2.86M | ﹤0.01% |
334,332
-108,816
| -25% | -$806K |
|
2578
Canadian Imperial Bank of Commerce
CM
$109B
| $2.86M | ﹤0.01% |
35,777
+18,757
| +110% | +$1.41M |
|
2579
Pediatrix Medical
MD
$2.17B
| $2.85M | ﹤0.01% |
170,319
-17,093
| -9% | -$256K |
|
2580
Knowles
KN
$3.2B
| $2.84M | ﹤0.01% |
122,031
-41,474
| -25% | -$849K |
|
2581
Adeia
ADEA
$3.05B
| $2.84M | ﹤0.01% |
169,152
-61,577
| -27% | -$912K |
|
|
BWIN
2582
Baldwin Insurance Group
BWIN
$2.82B
| $2.84M | ﹤0.01% |
100,641
-49,249
| -33% | -$1.71M |
|
2583
Global X Copper Miners ETF NEW
COPX
$7.37B
| $2.84M | ﹤0.01% |
47,456
-4,450
| -9% | -$215K |
|
|
ORLA
2584
DELISTED
Orla Mining
ORLA
| $2.83M | ﹤0.01% |
262,432
+39,148
| +18% | +$419K |
|
|
SEI
2585
Solaris Energy Infrastructure
SEI
$3.4B
| $2.83M | ﹤0.01% |
70,761
-7,859
| -10% | -$246K |
|
2586
Xeris Biopharma Holdings
XERS
$1.38B
| $2.82M | ﹤0.01% |
346,639
-77,609
| -18% | -$516K |
|
2587
Spyre Therapeutics
SYRE
$8.27B
| $2.82M | ﹤0.01% |
168,330
-48,316
| -22% | -$788K |
|
2588
PUT
Rapid7
RPD
$682M
| $2.81M | ﹤0.01% |
150,000
| – | – |
|
2589
Northwest Bancshares
NWBI
$2.33B
| $2.81M | ﹤0.01% |
226,695
-57,562
| -20% | -$724K |
|
2590
Accel Entertainment
ACEL
$976M
| $2.81M | ﹤0.01% |
253,556
-17,190
| -6% | -$201K |
|
2591
Element Solutions
ESI
$9.21B
| $2.8M | ﹤0.01% |
111,297
-26,058
| -19% | -$650K |
|
2592
Blue Bird Corp
BLBD
$2.35B
| $2.8M | ﹤0.01% |
48,639
-14,350
| -23% | -$749K |
|
|
CALY
2593
Callaway Golf Company
CALY
$3.42B
| $2.8M | ﹤0.01% |
294,221
-68,147
| -19% | -$633K |
|
2594
Compañía de Minas Buenaventura
BVN
$7.72B
| $2.79M | ﹤0.01% |
114,724
+6,402
| +6% | +$120K |
|
|
OKLO
2595
PUT
Oklo
OKLO
$7.25B
| $2.79M | ﹤0.01% |
25,000
-160,200
| -87% | -$12.5M |
|
|
WSR
2596
DELISTED
Whitestone REIT
WSR
| $2.79M | ﹤0.01% |
227,240
+30,156
| +15% | +$380K |
|
2597
DHT Holdings
DHT
$3B
| $2.78M | ﹤0.01% |
232,373
-6,908
| -3% | -$80.1K |
|
2598
RxSight
RXST
$261M
| $2.78M | ﹤0.01% |
308,763
+234,253
| +314% | +$2.06M |
|
2599
Procept Biorobotics
PRCT
$1.06B
| $2.77M | ﹤0.01% |
77,671
-47,583
| -38% | -$2.17M |
|
2600
City Holding Co
CHCO
$2.06B
| $2.77M | ﹤0.01% |
22,374
-9,817
| -30% | -$1.23M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.